Alcohol withdrawal seizures
Reading File
Finding Sources
Finding Sources
Searching PubMed
"alcohol withdrawal seizures" AND management
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Searching PubMed
"alcohol withdrawal seizures" AND benzodiazepine
I have sufficient content from the textbooks to provide a thorough, well-cited answer. Here it is:
Alcohol Withdrawal Seizures
Pathophysiology
Chronic alcohol consumption causes upregulation of NMDA glutamate receptors and downregulation of GABA-A receptors as the CNS compensates for alcohol's inhibitory effects. When alcohol is abruptly stopped, the resulting imbalance produces CNS hyperexcitability - the substrate for withdrawal seizures. This is the same mechanism underlying the broader alcohol withdrawal syndrome (AWS).
Timing and Clinical Features
| Phase | Timing | Event |
|---|---|---|
| Early withdrawal | 6-24 h | Tremor, anxiety, insomnia, nausea, tachycardia |
| Hallucinosis | 12-48 h | Tactile > visual > auditory hallucinations |
| Seizures | 6-48 h (peak 24-48 h) | Generalized tonic-clonic |
| Delirium tremens | 60+ h (peaks day 5) | Agitation, fever, autonomic instability |
Key seizure characteristics:
- Seizures occur 6 to 48 hours after reduction or cessation of alcohol; 90% occur within 48 hours
- Typically generalized tonic-clonic (rarely partial - focal seizures should prompt imaging)
- 90% of patients who seize have 1-6 seizures; 60% have multiple seizures within a 6-hour period
- Short or absent postictal period is common
- Status epilepticus is rare in pure alcohol withdrawal
- ~1/3 of patients with withdrawal seizures go on to develop delirium tremens
- Alcohol withdrawal seizures account for approximately one-third of all hospital admissions for seizures
(Rosen's Emergency Medicine; Tintinalli's Emergency Medicine; Bradley & Daroff's Neurology in Clinical Practice)
Risk Factors for Seizures
- Prior history of alcohol withdrawal seizure - the single strongest predictor
- Prior delirium tremens
- High and prolonged alcohol intake
- Multiple prior detoxifications (kindling effect)
- Comorbid seizure disorders, structural brain lesions
- Older age
- Concurrent use of other substances
Differential Diagnosis
Before attributing a seizure to alcohol withdrawal, exclude:
- Traumatic brain injury / intracranial hemorrhage (especially subdural - common in alcoholics from falls)
- Hypoglycemia (always check point-of-care glucose)
- Hyponatremia, hypomagnesemia
- CNS infection (meningitis, encephalitis)
- Non-compliance with antiepileptic medications
- Idiopathic epilepsy
- Withdrawal from other sedatives (benzodiazepines, barbiturates, baclofen)
- Toxic ingestion (isoniazid, tricyclics, stimulants, organophosphates)
- Wernicke's encephalopathy
Focal seizures or focal deficits in the postictal period mandate urgent CT head.
Workup
- Point-of-care glucose - mandatory first step
- Basic metabolic panel: sodium, magnesium, phosphate, calcium
- Liver function tests, CBC
- Toxicology screen
- CT head: indicated for new-onset seizures, focal features, trauma history, or failure to return to baseline
- LP if meningitis/encephalitis is suspected
- CIWA-Ar scale to assess withdrawal severity
Treatment
First-line: Benzodiazepines - the mainstay of therapy. They act at GABA-A receptors, directly counteracting the neurochemical defect, and are effective for both active seizure termination and prevention of further seizures.
| Agent | Dose (IV) | Notes |
|---|---|---|
| Diazepam | 10-20 mg IV over 2 min; repeat q5-10 min | Long-acting; active metabolites provide self-tapering effect |
| Lorazepam | 2-4 mg IV; repeat q15-20 min | Preferred in liver disease; no active metabolites |
| Oxazepam | 15-30 mg PO | Good for mild withdrawal; preferred in liver disease |
No single benzodiazepine is superior to the others for alcohol withdrawal seizures. IV is preferred when the patient is actively seizing or vomiting. IM lorazepam and midazolam have reliable absorption; IM diazepam is erratic.
Uncomplicated withdrawal (no seizures, no DT): Oral benzodiazepines with symptom-triggered dosing guided by CIWA-Ar scoring.
Refractory cases (failure to respond to ~50-100 mg diazepam equivalent in the first hour):
- Phenobarbital 65 mg IV q15-30 min up to 260 mg - acts on a different site of the GABA-A receptor; often requires intubation due to respiratory depression
- Propofol 5 mcg/kg/min titrated to effect - virtually always requires intubation; risk of propofol infusion syndrome with prolonged use (>48 h at >5 mg/kg/h)
- Dexmedetomidine - useful adjunct for autonomic symptoms
(Tintinalli's, Table 185-2; Bradley & Daroff's Neurology)
What NOT to use:
- Phenytoin is ineffective for alcohol withdrawal seizures and may in fact lower the seizure threshold. It is not indicated.
Supportive Care
- Thiamine 100 mg IV/IM before any glucose administration (prevent precipitating Wernicke's)
- Folate 1 mg daily
- IV fluids for dehydration
- Correct electrolytes: hypokalemia, hypomagnesemia, hypophosphatemia are common
- Quiet, low-stimulation environment
- Close monitoring of vital signs and respiratory status
Special Considerations
Prior history of withdrawal seizures: Start benzodiazepines early - most seizures occur within the first 24 hours. Initial dose: lorazepam 2 mg IV or diazepam 5 mg IV, frequently repeated.
Partial/focal seizures: Up to 50% of alcohol-related seizures are partial, and ~20% of those have underlying structural lesions (hematoma, tumor, vascular malformation). Emergent CT is indicated for new-onset partial seizures.
New-onset seizures: Require full workup. If imaging, labs, and exam are normal and the patient remains seizure-free with no withdrawal signs after 4-6 hours of observation, discharge is appropriate with outpatient follow-up. Long-term antiepileptic therapy is not indicated for pure alcohol withdrawal seizures.
Disposition
| Indication | Disposition |
|---|---|
| Mild withdrawal, responds to ED treatment, no major comorbidities | Detox unit or discharge home with reliable caregiver + outpatient referral |
| Alcohol withdrawal seizure | Admit |
| Prior DT, advanced age, withdrawal not responding to treatment | Admit |
| Refractory withdrawal requiring phenobarbital/propofol | ICU |
Follow-up within 24-48 hours is recommended for discharged patients.
Sources:
- Rosen's Emergency Medicine: Concepts and Clinical Practice (10th ed.)
- Tintinalli's Emergency Medicine: A Comprehensive Study Guide (9th ed.), Ch. 185
- Bradley and Daroff's Neurology in Clinical Practice (8th ed.)
- Frameworks for Internal Medicine
Ciwa scale
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have everything needed for a complete, well-sourced answer on the CIWA-Ar scale.
CIWA-Ar Scale (Clinical Institute Withdrawal Assessment for Alcohol, Revised)
The CIWA-Ar was developed in 1989 as a revision of the original CIWA-A. It is a validated, 10-item observer-rated scale used to:
- Quantify the severity of alcohol withdrawal
- Guide symptom-triggered benzodiazepine dosing
- Monitor treatment response
- Determine appropriate care setting
Takes approximately 5 minutes to complete. The CIWA-Ar is not copyrighted and may be reproduced freely.
The 10 Items
Each item is scored on an anchored scale. Most items are scored 0-7; orientation is scored 0-4. Maximum total score = 67.
1. Nausea and Vomiting
Ask: "Do you feel sick to your stomach? Have you vomited?"
| Score | Description |
|---|---|
| 0 | No nausea, no vomiting |
| 1 | Mild nausea, no vomiting |
| 4 | Intermittent nausea with dry heaves |
| 7 | Constant nausea, frequent dry heaves and vomiting |
2. Tremor
Observe with arms extended and fingers spread apart.
| Score | Description |
|---|---|
| 0 | No tremor |
| 1 | Not visible but can be felt fingertip to fingertip |
| 4 | Moderate, with patient's arms extended |
| 7 | Severe, even with arms not extended |
3. Paroxysmal Sweats
Observation only.
| Score | Description |
|---|---|
| 0 | No sweat visible |
| 1 | Barely perceptible sweating, palms moist |
| 4 | Beads of sweat obvious on forehead |
| 7 | Drenching sweats |
4. Anxiety
Ask: "Do you feel nervous?"
| Score | Description |
|---|---|
| 0 | No anxiety, at ease |
| 1 | Mildly anxious |
| 4 | Moderately anxious or guarded, anxiety inferred |
| 7 | Equivalent to acute panic states seen in severe delirium or acute schizophrenia |
5. Agitation
Observation only.
| Score | Description |
|---|---|
| 0 | Normal activity |
| 1 | Somewhat more than normal activity |
| 4 | Moderately fidgety and restless |
| 7 | Paces back and forth during most of the interview, or constantly thrashes about |
6. Tactile Disturbances
Ask: "Do you have any itching, pins and needles sensations, any burning, or any numbness, or do you feel bugs crawling on or under your skin?"
| Score | Description |
|---|---|
| 0 | None |
| 1 | Very mild itching, pins and needles, burning or numbness |
| 2 | Mild |
| 3 | Moderate |
| 4 | Moderately severe hallucinations |
| 5 | Severe hallucinations |
| 6 | Extremely severe hallucinations |
| 7 | Continuous hallucinations |
7. Auditory Disturbances
Ask: "Are you more aware of sounds around you? Are they harsh? Do they frighten you? Are you hearing anything that is disturbing to you? Are you hearing things you know are not there?"
| Score | Description |
|---|---|
| 0 | Not present |
| 1 | Very mild harshness or ability to frighten |
| 2 | Mild harshness or ability to frighten |
| 3 | Moderate harshness or ability to frighten |
| 4 | Moderately severe hallucinations |
| 5 | Severe hallucinations |
| 6 | Extremely severe hallucinations |
| 7 | Continuous hallucinations |
8. Visual Disturbances
Ask: "Does the light appear to be too bright? Is its color different? Does it hurt your eyes? Are you seeing anything that is disturbing to you? Are you seeing things you know are not there?"
| Score | Description |
|---|---|
| 0 | Not present |
| 1 | Very mild sensitivity |
| 2 | Mild sensitivity |
| 3 | Moderate sensitivity |
| 4 | Moderately severe hallucinations |
| 5 | Severe hallucinations |
| 6 | Extremely severe hallucinations |
| 7 | Continuous hallucinations |
9. Headache / Fullness in Head
Ask: "Does your head feel different? Does it feel like there is a band around your head?" (Do not rate for dizziness or light-headedness.)
| Score | Description |
|---|---|
| 0 | Not present |
| 1 | Very mild |
| 2 | Mild |
| 3 | Moderate |
| 4 | Moderately severe |
| 5 | Severe |
| 6 | Very severe |
| 7 | Extremely severe |
10. Orientation and Clouding of Sensorium
Ask: "What day is this? Where are you? Who am I?"
| Score | Description |
|---|---|
| 0 | Oriented and can do serial additions |
| 1 | Cannot do serial additions or is uncertain about date |
| 2 | Disoriented for date by no more than 2 calendar days |
| 3 | Disoriented for date by more than 2 calendar days |
| 4 | Disoriented for place or person |
Score Interpretation and Management
| CIWA-Ar Score | Severity | Action |
|---|---|---|
| < 8 | Mild | Monitoring only; medications rarely needed |
| 8-15 | Moderate | Pharmacotherapy likely needed; moderate benzodiazepine doses |
| > 15 | Severe | Close monitoring mandatory; high-dose benzodiazepines; risk of seizures and DT |
| > 10 + comorbidities | - | Hospital admission; IV thiamine; specialist care |
Note: Maudsley uses a slightly different cutoff - CIWA-Ar >10 as the threshold to prompt pharmacologically assisted withdrawal. Rosen's EM uses < 8 = mild (no medication), 8-15 = moderate, >15 = severe.
Care Setting by Severity
| Severity | Setting |
|---|---|
| CIWA-Ar ≤10, no comorbidities | Home with supportive carer |
| CIWA-Ar ≤15, low risk | Home or community team |
| CIWA-Ar >15 | Community team or hospital |
| CIWA-Ar >10 + alcohol-related medical problems | Hospital |
Inpatient detoxification is required if: prior seizures or DT, consumption >30 units/day, SADQ >30 (severe dependence), concurrent benzodiazepine use, pregnancy, significant comorbid illness, or no social support.
Symptom-Triggered vs. Fixed-Schedule Dosing
The CIWA-Ar enables symptom-triggered dosing - benzodiazepines are given only when scores exceed a threshold (typically ≥8-10), rather than on a fixed schedule. This approach has been shown to reduce total benzodiazepine doses and shorten duration of treatment compared to fixed-schedule regimens, without compromising safety.
Important Limitations
- Requires a cooperative, communicative patient - unreliable in patients who are intubated, severely encephalopathic, or unable to answer questions
- Does not directly predict seizure risk (though high scores correlate with it)
- Can be confounded by comorbid conditions (e.g., pain, anxiety disorders, hepatic encephalopathy)
- In non-communicative ICU patients, alternative tools such as the MINDS (Minnesota Detoxification Scale) may be used
Sources:
- Tintinalli's Emergency Medicine: A Comprehensive Study Guide (9th ed.), Table 185-5
- Maudsley Prescribing Guidelines in Psychiatry (15th ed.), Figure 4.1 & Table 4.4
- Rosen's Emergency Medicine (10th ed.)
This is a shared conversation. Sign in to Orris to start your own chat.